0001225208-12-007976.txt : 20120319 0001225208-12-007976.hdr.sgml : 20120319 20120319173334 ACCESSION NUMBER: 0001225208-12-007976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120315 FILED AS OF DATE: 20120319 DATE AS OF CHANGE: 20120319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 508-650-8000 MAIL ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NICHOLAS PETER M CENTRAL INDEX KEY: 0000901458 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 12701624 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 4 1 doc4.xml X0304 4 2012-03-15 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901458 NICHOLAS PETER M ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2012-03-15 4 J 0 18600.0000 0.0000 D 3512421.0000 I By Ltd. Partnership Common Stock 9083833.0000 D Common Stock 2413088.0000 I By Trust 2 Forward Sale Contract (obligation to sell) 2012-03-15 4 J 0 18600.0000 0.0000 D 2012-03-15 2012-03-15 Common Stock 18600.0000 0.0000 I By Ltd. Partnership On March 1, 2010, a family limited partnership of which the reporting person is a general and limited partner, Promerica L.P. ("Promerica"), entered into a trading plan intended to comply with the requirements of Rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. On March 15, 2012, Promerica settled a prepaid variable contract originally entered into on March 15, 2010 through the delivery of 18,600 shares of the Issuer's common stock. At the initiation of the contract, the bank paid $91,091.32 to Promerica. See also footnote 2. In accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 18,600 shares. If the market price per share at maturity was equal to or less than the floor price of $6.7972 per share, Promerica would deliver 18,600 shares to the bank. If the market price per share at maturity was greater than the floor price, Promerica would deliver a fewer number of shares. The market price per share at maturity on March 15, 2012 was $6.00. Accordingly, Promerica transferred 18,600 shares of the Issuer's common stock to the bank. Shares held by a trust of which the reporting person's spouse and brother are trustees and the reporting person's spouse and children are beneficiaries. pmnpoa.txt /s/ Conor Kilroy, Attorney-in-Fact 2012-03-19 EX-24 2 pmnpoa.txt POWER OF ATTORNEY Know all by these present that the undersigned hereby constitutes and appoints each of Timothy A. Pratt, Vance R. Brown, Theresa R. Boni, Todd D. Hammond, Conor Kilroy and Marissa S. Frerk signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5, and amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; (3) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of the Company, Forms 144 in accordance with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules and regulations thereunder; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 31st day of January, 2012. /s/ Peter M. Nicholas Peter M. Nicholas